Mangaluru | Cyanide Mohan convicted in 20th case

Bengaluru, May 21: Karnataka reported 116 fresh cases of coronavirus on Thursday, taking the state tally to 1578. 

So far, 570 people have been cured and discharged while 41 have succumbed to the virus, informed the state health department.

Out of the 116 cases, 71 have a history of inter-state travel history to Maharashtra.

Out of the 116 cases, 27 are from Udupi alone, 15 cases are reported from Mandya and 13 are from Hassan. Bengaluru Urban saw seven new cases.

Kalaburagi, Mar 16: In the wake of coronavirus scare, the public gatherings including local markets, village fairs, Urs festival in Kalaburagi district have been banned, said B Sharat, Deputy Commissioner, on Sunday.

"Gatherings including local markets, village fairs, Urs festival in the district have been banned as a precautionary measure against the coronavirus until further orders," Sharat said.

The World Health Organization (WHO) has declared that Europe has become the new 'epicenter' of the global coronavirus pandemic that has infected more than 15 lakh people with over 4,000 deaths globally.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.